Remicade approved for early arthritis treatment in Australia

03/29/2006 | Australian (tiered subscription model), The

Australia's Therapeutic Goods Administration has approved Remicade for early treatment of rheumatoid arthritis, a disease affecting more than 450,000 people in the country. Until now, Remicade was available to patients only after three years of other treatments, by which time patients often suffered significant joint damage.

View Full Article in:

Australian (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
Bend, OR
Clinical Appeals RN
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ